Related references
Note: Only part of the references are listed.Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications
Jaclyn N. Highland et al.
PHARMACOLOGICAL REVIEWS (2021)
A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R, 6R)-hydroxynorketamine and MK-801
Patrick J. Morris et al.
NEUROTOXICOLOGY AND TERATOLOGY (2021)
Ketamine: A tale of two enantiomers
Luke A. Jelen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Exogenous GM1 Ganglioside Attenuates Ketamine-Induced Neurocognitive Impairment in the Developing Rat Brain
Chen Meng et al.
ANESTHESIA AND ANALGESIA (2020)
GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions
Danielle M. Gerhard et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A novel method using ambient glutamate for the electrophysiological quantification of extrasynaptic NMDA receptor function in acute brain slices
Alexander Moldavski et al.
JOURNAL OF PHYSIOLOGY-LONDON (2020)
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
Chadi G. Abdallah et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Satoshi Deyama et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression
Katarzyna A. Dudek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Ketamine's dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant
Eli Lavender et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
Subanesthetic Ketamine Reactivates Adult Cortical Plasticity to Restore Vision from Amblyopia
Steven F. Grieco et al.
CURRENT BIOLOGY (2020)
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia
Mitchell J. Bartlett et al.
EXPERIMENTAL NEUROLOGY (2020)
A Review of Nonanesthetic Uses of Ketamine
Abby Pribish et al.
ANESTHESIOLOGY RESEARCH AND PRACTICE (2020)
NMDAR-independent, cAMP-dependent antidepressant actions of ketamine
Nathan H. Wray et al.
MOLECULAR PSYCHIATRY (2019)
Starting ketamine for neuroprotection earlier than its current use as an anesthetic/antiepileptic drug late in refractory status epilepticus
Denson G. Fujikawa
EPILEPSIA (2019)
Blockade of GluN2B-containing NMDA receptors reduces short-term brain damage induced by early-life status epilepticus
Cassio Morais Loss et al.
NEUROTOXICOLOGY (2019)
Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3 beta pathway
Ruiwei Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class
Jean Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Ketamine-induced attenuation of reactive oxygen species in zebrafish is prevented by acetyl L-carnitine in vivo
Bonnie Robinson et al.
NEUROSCIENCE LETTERS (2019)
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2019)
Targeting BDNF signaling by natural products: Novel synaptic repair therapeutics for neurodegeneration and behavior disorders
Sweta Bawari et al.
PHARMACOLOGICAL RESEARCH (2019)
Ketamine metabolite pilot study in a suicidal depression trial
Michael F. Grunebaum et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Potential link between antidepressant-like effects of ketamine and promotion of adult neurogenesis in the ventral hippocampus of mice
Jun Yamada et al.
NEUROPHARMACOLOGY (2019)
Influence of mTOR signaling pathway on ketamine-induced injuries in the hippocampal neurons of rats
Fei-fei Liu et al.
NEUROLOGICAL RESEARCH (2019)
Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
Kenichi Fukumoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Does general anesthesia affect neurodevelopment in infants and children?
Mary Ellen McCann et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects
S-X Li et al.
MOLECULAR PSYCHIATRY (2018)
Inhibition of GSK-3beta Signaling Pathway Rescues Ketamine-Induced Neurotoxicity in Neural Stem Cell-Derived Neurons
Jingjing Zhang et al.
NEUROMOLECULAR MEDICINE (2018)
Agmatine potentiates neuroprotective effects of subthreshold concentrations of ketamine via mTOR/S6 kinase signaling pathway
Mauren K. Tavares et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Midazolam Attenuates Autophagy and Apoptosis Caused by Ketamine by Decreasing Reactive Oxygen Species in the Hippocampus of Fetal Rats
Yanan Li et al.
NEUROSCIENCE (2018)
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G. Abdallah et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
Allie J. Widman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Administration of Ketamine Causes Autophagy and Apoptosis in the Rat Fetal Hippocampus and in PC12 Cells
Xinran Li et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Blood Levels of Glutamate and Glutamine in Recent Onset and Chronic Schizophrenia
Caroline Madeira et al.
FRONTIERS IN PSYCHIATRY (2018)
History of anaesthesia The ketamine story - past, present and future
Georges Mion
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2017)
Effects of a ketamine metabolite on synaptic NMDAR function Reply
Panos Zanos et al.
NATURE (2017)
Effects of a ketamine metabolite on synaptic NMDAR function
Kanzo Suzuki et al.
NATURE (2017)
Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties
Heather Kang et al.
NEUROPHARMACOLOGY (2017)
POSTTRAUMATIC ADMINISTRATION OF A SUB-ANESTHETIC DOSE OF KETAMINE EXERTS NEUROPROTECTION VIA ATTENUATING INFLAMMATION AND AUTOPHAGY
C. -Q. Wang et al.
NEUROSCIENCE (2017)
Prolonged ketamine exposure induces increased activity of the GluN2B-containing N-methyl-D-aspartate receptor in the anterior cingulate cortex of neonatal rats
Saurabh S. Kokane et al.
NEUROTOXICOLOGY AND TERATOLOGY (2017)
Neuron-protective effect of subanesthestic-dosage ketamine on mice of Parkinson's disease
Jun-Chao Fan et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2017)
Ketamine-induced apoptosis in the mouse cerebral cortex follows similar characteristic of physiological apoptosis and can be regulated by neuronal activity
Qi Wang et al.
MOLECULAR BRAIN (2017)
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Gerard Sanacora et al.
JAMA PSYCHIATRY (2017)
Effects of Ketamine on Levels of Inflammatory Cytokines IL-6, IL-1β, and TNF-α in the Hippocampus of Mice Following Acute or Chronic Administration
Yanning Li et al.
FRONTIERS IN PHARMACOLOGY (2017)
PACAP Protects Adult Neural Stem Cells from the Neurotoxic Effect of Ketamine Associated with Decreased Apoptosis, ER Stress and mTOR Pathway Activation
Shiva Mansouri et al.
PLOS ONE (2017)
Antidepressant Actions of Ketamine Versus Hydroxynorketamine
Graham L. Collingridge et al.
BIOLOGICAL PSYCHIATRY (2017)
In Vogue: Ketamine for Neuroprotection in Acute Neurologic Injury
Josh D. Bell
ANESTHESIA AND ANALGESIA (2017)
Ketamine-induced inhibition of glycogen synthase kinase-3 contributes to the augmentation of α-amino-3-hydroxy-5-methylisoxazole--4-propionic acid (AMPA) receptor signaling
Eleonore Beurel et al.
BIPOLAR DISORDERS (2016)
Ketamine: 50 Years of Modulating the Mind
Linda Li et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2016)
Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
Bangkun Yang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation
M M Harraz et al.
MOLECULAR PSYCHIATRY (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition
Oliver H. Miller et al.
NEUROPHARMACOLOGY (2016)
Baicalin Attenuates Ketamine-Induced Neurotoxicity in the Developing Rats: Involvement of PI3K/Akt and CREB/BDNF/Bcl-2 Pathways
Daiying Zuo et al.
NEUROTOXICITY RESEARCH (2016)
NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism
Carly Kiselycznyk et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
IN VIVO AND IN VITRO KETAMINE EXPOSURE EXHIBITS A DOSE-DEPENDENT INDUCTION OF ACTIVITY-DEPENDENT NEUROPROTECTIVE PROTEIN IN RAT NEURONS
B. P. Brown et al.
NEUROSCIENCE (2015)
BDNF Release Is Required for the Behavioral Actions of Ketamine
Ashley E. Lepack et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Dual Effects of Ketamine: Neurotoxicity Versus Neuroprotection in Anesthesia for the Developing Brain
Jia Yan et al.
JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY (2014)
Co-activation of synaptic and extrasynaptic NMDA receptors by neuronal insults determines cell death in acute brain slice
Zhuoyou Chen et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
Matthew P. Parsons et al.
NEURON (2014)
Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses
Erinn S. Gideons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
GluN2B-Containing NMDA Receptors Regulate Depression-Like Behavior and are Critical for the Rapid Antidepressant Actions of Ketamine
Oliver H. Miller et al.
ELIFE (2014)
Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade
Elena Nosyreva et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Ketamine Enhances Human Neural Stem Cell Proliferation and Induces Neuronal Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Pathway
Xiaowen Bai et al.
ANESTHESIA AND ANALGESIA (2013)
The Role of Eukaryotic Elongation Factor 2 Kinase in Rapid Antidepressant Action of Ketamine
Lisa M. Monteggia et al.
BIOLOGICAL PSYCHIATRY (2013)
Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
Elena Nosyreva et al.
JOURNAL OF NEUROSCIENCE (2013)
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Pierre Paoletti et al.
NATURE REVIEWS NEUROSCIENCE (2013)
NMDA receptors in nervous system diseases
Qiang Zhou et al.
NEUROPHARMACOLOGY (2013)
The blockade of NMDA receptor ion channels by ketamine is enhanced in developing rat cortical neurons
Jianhui Jin et al.
NEUROSCIENCE LETTERS (2013)
Developmental neurotoxicity of ketamine in pediatric clinical use
Chaoxuan Dong et al.
TOXICOLOGY LETTERS (2013)
NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors
X. Zhou et al.
CELL DEATH & DISEASE (2013)
Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
Rong-Jian Liu et al.
BIOLOGICAL PSYCHIATRY (2012)
Molecular pharmacology of human NMDA receptors
Maiken Hedegaard et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Ketamine Activates Cell Cycle Signaling and Apoptosis in the Neonatal Rat Brain
Sulpicio G. Soriano et al.
ANESTHESIOLOGY (2010)
Neuroprotection by Ketamine: A Review of the Experimental and Clinical Evidence
Judith A. Hudetz et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2010)
Memantine Preferentially Blocks Extrasynaptic over Synaptic NMDA Receptor Currents in Hippocampal Autapses
Peng Xia et al.
JOURNAL OF NEUROSCIENCE (2010)
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Giles E. Hardingham et al.
NATURE REVIEWS NEUROSCIENCE (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
Shawn E. Kotermanski et al.
JOURNAL OF NEUROSCIENCE (2009)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
The molecular neurobiology of depression
Vaishnav Krishnan et al.
NATURE (2008)
The excitotoxic effect of NMDA on human lymphocyte immune function
Anna P. Mashkina et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 Subunits
C. Thetford Smothers et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Regulation of NMDA receptors by phosphorylation
Bo-Shiun Chen et al.
NEUROPHARMACOLOGY (2007)
Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain
C Young et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms
T Sumiyoshi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
NMDA receptor subunits: diversity, development and disease
S Cull-Candy et al.
CURRENT OPINION IN NEUROBIOLOGY (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
